Login

BlackRock Favors Japan Stocks | Hiroyuki Shimizu, CEO, BlackRock Japan Co. Ltd.AS OF 07 MAR 2024 00:10:00

Share On Facebook Share On Twitter

Hiroyuki Shimizu is the CEO of BlackRock Japan Co. Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Understanding 10-Year Annualized Rolling Returns | David Hefty - CHIEF EXECUTIVE OFFICER of Credent Wealth Management
00:10:00
Markus Klahn, CEO of Intershop Communications AG, discusses the partnership with E/D/E and SHOPcloud360 in a conversation about Intershop's initiatives.|Markus Klahn, CEO of Intershop Communications AG,
00:10:00
Focused on investing in brilliant engineers|Dave Fontenot,General Partner,Backend Capital / Hf0
00:10:00
Paul Reilly, CEO of Raymond James, Discusses Economic Outlook and Company Strategy Amidst Uncertain Times|  Paul Reilly, CEO , Raymond James.
00:00:00
Q&A with Carbios Chief Executive Officer Emmanuel Ladent | EMMANUEL LADENT, CHIEF EXECUTIVE OFFICER, CARBIOS
00:10:00
Navigating Economic Challenges: Scott Kapnick on Deploying Private Debt Capital |Scott Kapnick, CEO, HPS Investment Partners
00:10:00
Allgeier share: Even more boost for THE German IT price rocket? | Carl Georg Dürschmidt, CEO, Allgeier SEAEIX.N:GER
00:10:00
Union Square Ventures is a venture capital firm focused on early-stage|John Buttrick,Partner,Union Square Ventures
00:10:00
Unlocking the Power of Your Stimulus Check: Step 4 of 5 Vital Financial Moves | Wakefield Hare - Financial Planner, Greater Than Financial
00:10:00
Navigating Over-Enforcement: Insights from Robert M. Cary, Partner at Williams & Connolly LLP | Robert M. Cary - Partner, Williams & Connolly LLP
00:10:00
A2A's Alumni to Alumni features inspiration and insights, with a CEO spotlight on Priscilla Almodovar joining Fannie Mae as CEO.
00:10:00
Top Absolute Return Performers: Fatima Khizou’s Picks for Consistent Gains Across Market Cycles | Fatima Khizou - Fund Analyst, Morningstar

© 2017 - Neuhu+